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Abstract 
The purpose was to evaluate muscle deoxygenation (Δ[HHb]), oxygen uptake (VO2), 
ventilation (VE), and arterialized blood lactate [La-] throughout exhaustive incremental 
(RAMP) and severe-intensity exercise (SI) during follicular (FOL) and luteal (LUT) 
menstrual phases. During RAMP, Δ[HHb]/VO2 was 65% lower in LUT below gas exchange 
threshold (p<0.05), without changes in VO2, VE and Δ[HHb] (p>0.05). During SI, 
Δ[HHb]/VO2 was 18% lower in LUT during the kinetic phase (p<0.05), VE was higher (FOL: 
83 ± 19 L×min-1; LUT: 89 ± 17 L×min-1) and post-SI [La-] were lower (FOL: 12.9 ± 2.5 
mmol×L -1; LUT: 11.7 ± 1.7 mmol×L -1) (p<0.05), without differences in VO2 and Δ[HHb] 
(p>0.05). No FOL/LUT differences in RAMP-performance (FOL: 218 ± 35 W; LUT: 221 ± 
29 W) or SI-endurance (FOL: 99 ± 20 s; LUT: 96 ± 15 s) (p>0.05) were found. These data 
demonstrate that physiological differences between menstrual phases exist, however, 
performance is unaffected.  
Keywords 
Muscle deoxygenation, near infrared spectroscopy, breath-by-breath pulmonary O2 uptake, 
gas exchange, ramp incremental exercise, heavy intensity exercise, menstrual cycle 
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Chapter 1  
1 « Review of Literature » 
Eumenorrheic females experience cyclic fluctuations of ovarian hormones estrogen and 
progesterone every 20 - 45 days through the naturally occurring menstrual cycle (Lebrun, 
Joyce, & Constantini, 2013). Amongst reproductive functions, these hormonal 
fluctuations have been shown to effect both cardiorespiratory and metabolic responses to 
exercise which might influence overall performance. As such, this day to day variability 
of female hormones has led to an under-representation of female participants compared to 
males in sport and exercise studies. For example, in a review by Bruinvels et al. (2017) of 
1382 exercise studies 2011 to 2013, it was found that female participants were involved 
in only 39% of studies (Bruinvels et al., 2017). Further, studies that did include female 
participants often only tested women in the early-follicular phase of the menstrual cycle 
when ovarian hormones estrogen and progesterone are known to be in lowest 
concentration, in an attempt to minimize any possible hormonal effects. Although this 
research is beneficial in understanding sex differences within exercise response, it leaves 
many unanswered questions regarding the influence of female hormones on the 
physiological and performance response to exercise throughout the female menstrual 
cycle. Finally, menstrual cycle (MC) exercise research that exists in the literature lacks 
methodological consistency pertaining to menstrual phase verification and the timing of 
testing throughout the MC, and as such, presents equivocal results (Bruinvels et al., 
2017). The present study aims to determine the physiological and performance effects of 
ovarian hormones during exhaustive ramp incremental and subsequent severe-intensity 
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step exercise in the early-follicular (FOL) and mid-luteal (LUT) menstrual phases, when 
hormones are known to be at the lowest and highest concentrations, respectively.  
This chapter will review the background literature of menstrual phase exercise 
research pertaining to ramp incremental exercise and severe-intensity constant load 
exercise. Specifically, the physiology of the menstrual cycle, aerobic capacity and 
performance, cardiovascular function, and substrate metabolism will be discussed to 
underpin the rationale for the study. Thereafter, an overview of equipment and 
cardiorespiratory and metabolic data collection processes, as well as the relevance to this 
research study, will be presented.  
1.1 « The Female Menstrual Cycle » 
Through the years of adolescence and puberty, across the reproductive years to post-
menopause, a woman’s physiology changes substantially. During reproductive years, 
ovarian hormones estrogen (Est) and progesterone (Pro) fluctuate 2-10-fold throughout 
the ~ 28-day MC to support reproductive function of eumenorrheic females (Lebrun et 
al., 2013). The physiological differences pertaining to oxygen uptake, blood lactate, and 
ventilation associated with menstrual phase hormonal variability suggests that studying 
females adds a complexity female research that is not observed with research on males. 
Exercise performance is a multifaceted entity – there is an intricate interaction of 
cardiovascular, respiratory and metabolic variables that enable the body to exercise and 
perform successfully, that is further complicated by endocrinological factors. This section 
will review the physiology of the menstrual cycle, followed by the known effects of the 
menstrual phase on aerobic capacity and performance, cardiorespiratory function, and 
substrate metabolism. 
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1.1.1 « Physiology of the Menstrual Cycle » 
The MC lasts ~ 28 days (range 21 – 45 days) in eumenorrheic women and is divided into 
three main components, known as the follicular, ovulatory, and luteal phases, each with a 
unique hormonal profile based on physiological changes that occur throughout the cycle, 
as shown in Figure 1.  
 
Briefly, the follicular phase begins on cycle Day 1, marked by the onset of 
menses, and is accompanied by low concentrations of Est and Pro. In the late follicular 
 
Figure 1. Ovarian and pituitary hormone concentrations across the female 
menstrual cycle. (FSH) Follicle stimulating hormone; (LH) Luteinizing hormone; 
(FOL) Follicular; (OVL) Ovulatory; (LUT) Luteal; (mlU•mL-1) Milli-international 
units per millilitre; (pg•mL-1) Pictograms per millilitre; (ng•mL-1) Nanograms per 
millilitre. Figure modified from (Lebrun et al., 2013).   
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phase, [Est] increases, stimulating a surge in luteinizing hormone (LH), which releases 
the follicle (egg) from the ovaries on ~ Day 14, known as ovulation. After ovulation 
occurs, the released follicle is known as the corpus luteum, which secretes Est and Pro in 
a parabolic function throughout the luteal phase (Day 14 – 28), reaching peak 
concentrations on ~ Day 21 (Lebrun et al., 2013). The present study tests participants in 
the early-follicular (FOL; ~ Day 2 - 3) and the mid-luteal (LUT; ~ Day 20 - 22) phases. 
1.1.2 « Aerobic Capacity, Performance and the Menstrual Cycle » 
Apart from results of one study (Lebrun, McKenzie, Prior, & Taunton, 1995), aerobic 
capacity as measured by maximal oxygen uptake (VO2max) is not different across the MC 
(Bonen et al., 1983; De Souza, Maguire, Rubin, & Maresh, 1990; Dombovy, Bonekat, 
Williams, & Staats, 1987; Jurkowski, Jones, Walker, Younglai, & Sutton, 1978; Redman, 
Scroop, & Norman, 2003; Schoene, Robertson, Pierson, & Peterson, 1981). Lebrun et al. 
(1995) found that trained, eumenorrheic women had lower absolute VO2max in the LUT 
phase compared to FOL, without any differences in maximal endurance time-to-fatigue 
(TTF). In contrast, there are studies that have shown menstrual phase performance 
differences in endurance TTF despite no changes in VO2max (Jurkowski, Jones, Toews, & 
Sutton, 1981; Schoene et al., 1981), however, results are equivocal. Jurkowski et al. 
(1981) found that women exercising in the LUT phase at 90% of VO2max had a greater 
ventilation (VE), lower lactate ([La-]) production, and greater TTF compared to the FOL 
phase, where Schoene et al. (1981) found shorter TTF in the LUT phase compared to 
FOL, despite the same changes in VE and [La-] as presented by Jurkowski et al. (1981).  
 Moreover, oxygen uptake during submaximal exercise has presented differences 
between FOL and LUT phases. Redman et al. (2003) studied 14 sedentary females at 
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25% and 75% of VO2peak and found that [La-], carbon dioxide production (VCO2) and 
respiratory exchange ratio (RER) were lower in the LUT phase, while VO2 was higher. 
Hackney et al. (1994) also found that females exercising at 35% and 60% of VO2max had 
lower RER in the LUT phase compared to FOL phase without changes in VO2, VCO2, or 
[La-] (Hackney, McCracken, & Ainsworth, 1994). Hackney et al. (2000) studied women 
with high and low exogenous ovarian hormone concentrations (similar to the LUT and 
FOL phase of the MC, respectively) during prolonged exercise at 65% of VO2max, and 
observed mean VO2 during submaximal exercise that was trending towards being higher 
in the LUT phase compared to FOL (p=0.07; Cohen’s d = 0.5) (Hackney, Muoio, & 
Meyer, 2000). These results directly oppose findings from Lebrun et al. (1995), who 
found that oxygen uptake was lower in the LUT phase compared to FOL. Others have 
reported no differences in oxygen uptake during sub-maximal exercise (Gurd, Scheid, 
Paterson, & Kowalchuk, 2007). As evidenced by these ambivalent results, the literature 
available regarding the effect of menstrual phase on oxygen uptake and endurance 
performance are equivocal. 
1.1.3 « Cardiorespiratory Function » 
The known effects of Est and Pro on basal body temperature (BBT), ventilation, 
vasodilation, blood flow, pulmonary diffusion capacity, and total hemoglobin 
concentration have been shown to affect various physiological parameters during exercise 
within each phase of the MC. 
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For example, high [Pro] at the onset of the LUT phase instigates an increase in 
basal body temperature (BBT) of 0.3-0.5 0C that persists until the beginning of the 
subsequent cycle (Lebrun et al., 1995; Marshall, 1963; Schaumberg, Jenkins, Janse de 
Jonge, Emmerton, & Skinner, 2017; Stephenson & Kolka, 1993), causing a rightward 
shift of the oxyhemoglobin dissociation curve and subsequent reduction in oxygen 
affinity to hemoglobin and enhanced O2 delivery during the LUT phase (Lebrun et al., 
2013). LUT phase increases in chemoreceptor sensitivity to CO2 resulting in increases of 
resting and exercising VE have also been reported (Schoene et al., 1981). This increased 
ventilation facilitates buffering of [H+] removal via the carbonic anhydrase reaction and 
increases pH, thus eliciting a left-ward shift in the oxyhemoglobin dissociation curve, 
promoting oxygen affinity to hemoglobin (Dombovy et al., 1987). In terms of actual 
oxygen utilization, the LUT phase rise in BBT enhances O2 delivery, while the 
concomitant increase in VE promotes CO2 elimination, most likely leading to no net 
effect compared to FOL phase (Lebrun et al., 2013). Moreover, oxygen carrying capacity 
of the blood might be affected during menstruation (the early FOL phase). Most females 
discharge ~ 25 – 65 mL of blood during menses, however, heavy blood loss can exceed 
200 mL in some women, leading to anemia and reduced O2 carrying capacity in the FOL 
phase compared to LUT (Reilly, 2010).  In contrast, there have also been reports of no 
differences in total hemoglobin concentration across the MC (Smith, Brown, Murphy, & 
Harms, 2015).  
Furthermore, high [Est] has been reported to enhance endothelium-dependent 
vasodilation in coronary and peripheral vessels of post-menopausal women (Gerhard et 
al., 1998; Gilligan, Quyyumi, Cannon, Johnson, & Schenke, 1994). As [Est] is high in the 
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LUT phase of the MC, these studies suggest that blood flow would also be enhanced in 
the large conductance arteries and the smaller microvascular resistance arteries, 
promoting O2 delivery. Farha et al. (2007) also found a LUT phase improvement in O2 
delivery, however, this improvement was not due to changes in vasodilation, but instead a 
temporary LUT phase pulmonary angiogenesis that resulted in increased surface area for 
diffusion, eliciting an improvement in microvascular blood flow distribution (Farha et al., 
2007).  Further, Smith et al. (2015) have also shown LUT-phase improvements in 
pulmonary diffusion capacity (Smith et al., 2015), however, such changes did not impact 
performance.  
Despite the apparent cardiovascular benefits in the LUT phase of the MC 
reviewed in this section, including improved oxygen delivery via increased ventilation, 
vasodilation, and pulmonary diffusion capacity, many studies show no performance 
differences between menstrual phases. The next section will review menstrual phase 
differences in substrate metabolism and discuss possible implications to performance 
across the MC.  
1.1.4 « Substrate Metabolism » 
There is evidence to suggest high concentrations of Est and Pro in the LUT phase of the 
MC shift substrate metabolism to favour lipids during sub-maximal exercise. Lower [La-] 
have been reported in the LUT phase compared to FOL phase (Jurkowski et al., 1981; 
McCracken, Ainsworth, & Hackney, 1994), attributed to estrogen-mediated preferential 
lipolysis and glycogen sparing mechanisms (Bunt, 1990; Hackney et al., 1994) through 
the upregulation of AMPK+ activity and enhanced entry of free fatty acids into beta-
oxidation (D'Eon et al., 2005). Other authours have reported a reduction in RER in the 
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LUT phase compared to FOL during prolonged sub-maximal exercise, indicating greater 
energy contribution from fat metabolism (Dombovy et al., 1987; Hackney, 1999; 
Hackney et al., 1994; Hackney et al., 2000; Redman et al., 2003). It is, however, 
important to note that if glucose is ingested prior-to or during exercise, menstrual phase 
differences in substrate oxidation do not persist (Campbell, Angus, & Febbraio, 2001). 
Exercise in a fasted state elicits menstrual phase differences in substrate metabolism, 
particularly an increase in LUT phase lipolysis during long duration, sub-maximal 
exercise bouts (Bonen et al., 1983).  
 
 
 
 
 
 
 
 
 
 
Figure 2. Effect of menstrual phase on respiratory exchange 
ratio (RER) during incremental exercise to exhaustion in 
sedentary women. (Closed circles Follicular phase, open 
circles LUT phase.) Values are mean (SE). *Significantly 
different from follicular phase, P<0.05). (Figure by Redman 
et. al, 2003). 
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1.2 « Ramp Incremental Exercise » 
Maximum oxygen uptake (VO2max) is achieved during exhaustive exercise using large 
muscle groups (running, cycling, swimming, etc.), providing an indication of the true 
limits of the O2 transport/utilization systems (Poole & Jones, 2017). Ramp incremental 
tests begin at a light intensity baseline and increase to supra-maximal workloads via 
linear increase in work rate. During 20 W•min-1 ramp incremental exercise, oxygen 
uptake increases until VO2max is attained. The gold standard for VO2max achievement is a 
plateau in oxygen uptake despite the continual increase in work rate, however, this is not 
seen on every on every occasion. VO2max testing is widely used in research and clinical 
laboratories, as well as sports and exercise facilities, as a determinant of maximal aerobic 
capacity.  
The present study required participants to perform one ramp incremental exercise 
test (20 W•min-1) to exhaustion within each menstrual phase, providing an assessment of 
the integrated functioning of the cardiorespiratory and metabolic systems, including the 
uptake, transport and utilization of O2 within the mitochondria of the contracting muscle. 
This section will review the different energy system contributions throughout a ramp 
incremental exercise test and the physiology involved in the determination of gas 
exchange threshold.  
1.2.1 « Energy Systems » 
A ramp incremental exercise test requires close integration of both glycolytic energy 
systems and aerobic metabolism (oxidative phosphorylation) to breakdown and utilize 
carbohydrates and fats and fulfil the adenosine triphosphate (ATP) requirements at the 
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muscle (Baker, McCormick, & Robergs, 2010). While assessing energy system 
contribution during incremental exercise, Damasceno et al. (2015) determined that the 
anaerobic/aerobic percent contribution to be ~ 94 / 6 % at the beginning and ~ 83 / 17 % 
at the end of the test, respectively (Damasceno, Pasqua, Lima-Silva, & Bertuzzi, 2015) 
(Figure 2 created by (Bertuzzi, 2013)).  
Glycolysis is the process of converting glucose (or glycogen) to pyruvate in the 
cytosol of the cell. Anaerobic glycolysis produces lactate from pyruvate, a process that 
generates a rapid, however limited, amount of ATP. Aerobic glycolysis occurs when 
pyruvate is transported to the mitochondria of the cell, converted to Acetyl-CoA, and 
enters the citric acid cycle. The citric acid cycle generates both ATP as well as electrons 
for passage to the electron transport chain (ETC) via high energy carriers NAD+ and 
FAD. An electrochemical proton gradient is established via the translocation of hydrogen 
ions [H+] from the matrix to the intermembrane space within the mitochondria which 
drives ADP phosphorylation and ultimately substantial ATP generation via ATP 
synthase. This is an aerobic process, as the final reaction requires the reduction of 
molecules of oxygen and the formation of water (H2O). Lipid (fatty acid) oxidation is the 
most plentiful source of potential energy that exists in the body and is very important 
during aerobic metabolism during longer duration steady state exercise (Baker et al., 
2010). Following the breakdown of a triglyceride into three fatty acids and a glycerol, the 
fatty acids are transported into the mitochondrial matrix where they undergo ß-oxidation 
to generate Acetyl-CoA, which is further metabolized in the citric acid cycle and electron 
transport chain to generate high energy carriers and ultimately ATP (Katch, McArdle, & 
Katch, 2011).   
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During exercise, there is an increase in ATP demand and thus, an increase in O2 
utilization at the muscle, resulting in reduced O2 partial pressure (PO2) at the muscle 
(Whipp & Davis, 1979). A reduction in muscular PO2 stimulates O2 offloading of the 
myoglobin, as well as O2 offloading from hemoglobin in the surrounding 
microvasculature, resulting in a higher concentration of deoxygenated hemoglobin 
([HHb]) to maintain O2 delivery (Grassi, Quaresima, Marconi, Ferrari, & Cerretelli, 
1999). During ramp incremental exercise, [HHb] increases in a linear fashion until 
respiratory compensation threshold, where there is an evident plateau (Murias, Keir, 
Spencer, & Paterson, 2013). Exercising above respiratory compensation threshold results 
in hyperventilation and insufficient time for CO2 removal, ultimately resulting in fatigue 
and exercise cessation (Baker et al., 2010).  
 
Figure 3. Energy system contributions during incremental exercise test 
expressed as a percentage of the total metabolic demand. Mean of n=10 (± SD). 
Figure modified from original by (Bertuzzi, Nascimento, Urso, Damasceno, & 
Lima-Silva, 2013).  
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1.2.2 « Gas Exchange Threshold » 
Exercise above gas exchange threshold (GET) and respiratory compensation threshold 
are known as heavy- and severe-intensity exercise, respectively. During supra-GET 
exercise, cytosolic pyruvate production exceeds pyruvate oxidation, which accelerates 
anaerobic glycolysis and the lactate dehydrogenase reaction, resulting in an accumulation 
of lactate. To maintain electrical neutrality, lactic acid dissociates into [La-] and hydrogen 
ions, which are transported into the blood (Katch et al., 2011). In the presence of 
bicarbonate ions (HCO3-) in the blood, H+ binds to make carbonic acid, which then 
dissociates into carbon dioxide (CO2) and water, catalyzed by the carbon anhydrase 
reaction (Equation 1) (Belfry, Paterson, Murias, & Thomas, 2012), and thus increases 
CO2 partial pressure (PCO2) in the blood. As peripheral chemoreceptors are highly 
sensitive to PCO2 changes in arterial blood, the resulting hypercapnia stimulates 
increased ventilation in an attempt to remove CO2 from the blood. If H+ production 
persists beyond the capacity of ventilatory buffering, known as gas exchange threshold, 
H+ will accumulate and metabolic acidosis will persist.  In contrast, exercise below gas 
exchange threshold (GET) presents an increase in oxidative phosphorylation that is 
Equation 1. Interconversion of carbon dioxide and water to bicarbonate and 
protons via the carbonic anhydrase reaction. Figure derived from information by 
(Geers & Gerolf, 2000) 
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matched by CO2 production via the pyruvate to Acetyl-CoA reaction and the citric acid 
cycle. As such, at sub-GET workrates, VO2 and VCO2 stabilize in 3 and 4 minutes, 
respectively (Xu & Rhodes, 1999).  
1.3 « Severe-Intensity Step Exercise » 
Following the RAMP protocol, participants in the present study performed a 5-minute 
baseline cycle at 20 W, followed by a step increase to an individually determined supra-
maximal workload. Participants cycled at a cadence of 70 rpm until volitional fatigue or 
the cycling cadence could no longer be maintained, lasting ~ 90 seconds.  
As outlined by Gastin (2001), the anaerobic/aerobic percent contribution during 
90 second maximal effort exercise is ~ 44 / 56 % (Gastin, 2001).  At the immediate onset 
of the workload, energy is immediately supplied through the Adenosine Triphosphate-
Phosphocreatine (ATP-PCr) system. The high energy phosphagen, in combination with 
stored ATP within the muscle cell, provide high power and short duration energy supply 
at the very beginning of heavy intensity exercise (Gastin, 2001). Along with a 
contribution from the ATP-PCr energy system, anaerobic glycolysis is another major 
energy supply. Exercising at such a high intensity elicits an accumulation of CO2 that 
results in metabolic acidosis and ultimately fatigue.  
1.4 « Breath by Breath Analysis of Mass Spectrometry » 
In the present study, pulmonary oxygen uptake (VO2p) is measured at the mouth via 
breath-by-breath analysis, reflecting the contribution of oxidative phosphorylation to 
exercising energy supply. VO2p, carbon dioxide output (VCO2p), and minute ventilation 
(VE) values were calculated by inspired and expired flow rates from a low dead-space (90 
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mL) bi-directional turbine. After calibrating with fixed gas mixtures, inspired and expired 
gases were sampled continuously at the mouth and analyzed for concentrations of O2 and 
CO2 by mass spectrometry. Breath-by-breath gas exchange were calculated using 
algorithms that were developed to estimate alveolar gas exchange by accounting for 
changes in both functional residual capacity and alveolar gas concentrations during 
ventilation (Swanson & Sherrill, 1981). Total lung gas exchange was calculated and 
changes in gas concentration were aligned with gas volumes by measuring time delay for 
a square-wave bolus of gas passing through the turbine, resulting in changes in fractional 
gas concentrations as measured by the mass spectrometer every 20 milliseconds. Data 
were transferred to a computer that aligned concentrations with volumes to build a profile 
of each breath. 
1.5 « Near Infrared Spectroscopy and Muscle 
Deoxygenation » 
Near infrared spectroscopy (NIRS) is a method of continuous and non-invasive 
monitoring of muscle deoxygenation (HHb), oxygenated hemoglobin (O2Hb), total 
hemoglobin (THb) and tissue hemoglobin saturation (O2Sat) at the site of interrogation 
during dynamic exercise (Belfry et al., 2012; Gurd et al., 2007; McCrudden, Keir, & 
Belfry, 2017; K. Smith & Billaut, 2012). At the onset of exercise, PO2 in the exercising 
muscle is reduced, thus increasing the PO2 gradient and increasing O2 delivery via 
enhanced O2 offloading from hemoglobin (Hb), until the time in which O2 delivery by 
blood flow increases (Laughlin & Armstrong, 1985). PO2 during exercise can be affected 
by a variety of factors, including body temperature and ventilation, both of which are 
affected by the menstrual cycle, as discussed previously (Lebrun et al., 2013). Muscle 
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deoxygenation reflects the balance between oxygen delivery and utilization, and thus, 
provides important information regarding the adequacy of the vascular response and PO2 
gradient (Koga et al., 2011).   
The theoretical basis for NIRS technology is comprehensively explained by 
Ferrari et. al (2004) (Ferrari, Mottola, & Quaresima, 2004). Briefly, between the visible 
and microwave domains of the electromagnetic spectrum is infrared light. Infrared 
spectroscopy exposes organic molecules hemoglobin (Hb) and myoglobin (Mb) to 
infrared radiation, ranging from 790 – 850 nm. Upon exposure, Hb and Mb resonate at 
these wavelength frequencies and are absorbed. Measurements are determined by the 
amount of absorption of the near-infrared light by Hb and Mb, as projected by laser 
diodes refracted back to the optode from muscle tissue at the area of interrogation. 
Deoxygenated hemoglobin (HHb) and oxygenated hemoglobin (O2Hb) absorb different 
wavelengths of near-infrared (NIR) light depending on the presence of O2-binding (690 – 
760 nm and 800 – 850 nm, respectively). The difference in wavelengths emitted by the 
NIRS optode provides measures of [HHb], [O2Hb] and [THb] (Koga et al., 2011).  
The present study uses NIRS Oxiplex TA (model 95205, ISS, Champaign, IL) 
(technical reference (Franceschini, 2002). The emission probe carrying NIR light was 
arranged as a single channel consisting of eight laser diodes operating at two wavelengths 
(690 and 828 nm, 4 at each wavelength) that were pulsed in a rapid succession (frequency 
modulation of laser intensity was 110 MHz). Optodes were contained in an optically 
dense plastic holder, which were placed on the muscle belly of the vastus lateralis half-
way between the lateral epicondyle and greater trochanter of the femur, and secured by a 
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black vinyl sheet and a tensor bandage to prevent any intrusion of extraneous light and 
movement of the probe.  
Profiles of [HHb] during ramp incremental exercise in both men and women have 
been described by Murias et. al (2013). In short, both sexes show an increase in [HHb] 
until an evident ‘plateau’ at the respiratory compensation threshold, however, women 
demonstrate a greater overall reliance on local O2 extraction (greater [HHb]) compared to 
men. Possible menstrual phase effects on local muscle deoxygenation during ramp 
incremental and severe intensity exercise have not been previously explored and is one of 
the purposes of the present study.   
1.6 « Study Rationale » 
Women are often under-represented in exercise physiology research, and as such, the 
confounding effects of the menstrual cycle on exercise response are largely unknown 
(Bruinvels et al., 2017). In performing a ramp incremental exercise test followed by a 
severe-intensity constant load bout, researchers gain a complete pulmonary and metabolic 
profile that presents any changes that might exist between menstrual phases.  
The main purpose of this study was to compare VO2, [La-], VE, vastus lateralis 
DHHb, and performance (time-to-fatigue) in both the early-follicular (FOL) and mid-
luteal (LUT) phases of the menstrual cycle during ramp incremental and subsequent 
severe-intensity constant load exercise to limit of tolerance. This information will provide 
valuable insight to female physiology and any potential exercise performance 
implications associated with such changes. 
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Chapter 2  
2 « Menstrual Phase Differences in Muscle 
Deoxygenation, Respiration, and Blood Lactate 
Concentration Do Not Influence Exercise Performance» 
The menstrual cycle is composed of luteal (LUT) and follicular (FOL) phases wherein 
the ovarian hormones estrogen and progesterone are at their highest and lowest 
concentrations, respectively (Lebrun, Joyce, & Constantini, 2013).  Notably, the vast 
majority of the exercise physiology literature has not included female participants in their 
participant pools because it is often taken for granted that the different phases of the 
menstrual cycle evoke increased day-to-day variability in physiological and performance 
variables (for review, see (Oosthuyse & Bosch, 2010).  It is, however, important to 
recognize that a small pool of research examining the impact of the menstrual phase on 
the physiological responses during exercise is equivocal and is to be elucidated here.  
On the one hand, Redman et. al (2003) reported increased oxygen uptake (VO2) in 
the LUT phase during moderate- (25% of VO2peak) and heavy-intensity (75% of VO2peak) 
exercise compared to the FOL phase.  This finding was attributed to the LUT phase 
eliciting increased fat and decreased carbohydrate oxidation resulting in a lower 
respiratory exchange ratio (RER). On the other hand, Lebrun et al. (1995) found a 
modest, but reliable reduction in VO2peak in the LUT phase over the continuum of 
increasing work rates during a ramp exercise protocol; however, the authors did not offer 
a mechanism for this difference.  Further, it is important to recognize that a number of 
studies have reported that LUT and FOL phases are associated with equivalent VO2 
measures for moderate-intensity exercise (Gurd, Scheid, Paterson, & Kowalchuk, 2007) 
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as well as exhaustive ramp exercise (Jurkowski, Jones, Walker, Younglai, & Sutton, 
1978; Redman, Scroop, & Norman, 2003; Schoene, Robertson, Pierson, & Peterson, 
1981). 
Increases in the carbohydrate contribution to energy production associated with 
the imbalance between the rate of pyruvate production and oxidation that elicits increased 
cytoplasmic and blood lactate [La-] and [H+]. The increase in [H+] undergoes the carbonic 
anhydrase reaction, resulting in increased VCO2, which is a stimulus on ventilation (VE) 
to increase blood pH (Green, Hughson, Orr, & Ranney, 1983).  
In line with VO2 measures, the literature has shown mixed results for exercise-
based differences in [La-] concentration across LUT and FOL phases.  For example, 
Kendrick et al. (1991) found that estrogen supplementation in male rats resulted in 
decreased [La-] and increased time-to-exhaustion via glycogen sparing mechanisms 
compared to a control group. In exercising human female participants, decreased [La-] 
during the LUT compared to the FOL phase across moderate- to maximal-intensity 
exercise bouts has been reported (Jurkowski, 1981; Schoene, 1981; McCracken, 1994; 
Redman et al., 2003). This response was attributed to increased ventilatory buffering – a 
metabolically beneficial response reducing the accumulation of fatigue-inducing 
metabolites that is thought to positively impact endurance performance (Dombovy, 
Bonekat, Williams, & Staats, 1987). Jurkowski et al. (1981) observed that increased VE 
associated with ventilatory buffering resulted in improved time-to-fatigue (TTF) while 
exercising at 90% of VO2max. Others, however, have shown no menstrual phase 
differences in performance (Lebrun, McKenzie, Prior, & Taunton, 1995; McCracken, 
Ainsworth, & Hackney, 1994), despite findings of higher reported VO2max in the LUT 
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phase (Lebrun et al., 1995) and lower LUT phase post-exercise [La-] (McCracken, 1994; 
Redman et al., 2003).  Furthermore, several studies have shown LUT phase increases in 
VE (Jurkowski et al. 1981; Schoene et al. 1981) and decreases in [La-] during maximal 
effort exercise (Jurkowski et al. 1981; Schoene et al. 1981; Redman et al., 2003).  In 
contrast, Gurd et al. (2007) reported no exercise related changes in VE or [La-] changes 
between menstrual phases exercise suggesting consistent substrate metabolism across the 
menstrual cycle (Gurd et al., 2007).  
To our knowledge, no research examined putative menstrual phase differences in 
muscle deoxygenation (HHb) during exercise. It has been suggested, however, that 
females, compared to males, have a greater reliance on fractional oxygen (O2) extraction 
during ramp incremental exercise (Murias, Keir, Spencer, & Paterson, 2013).  This sex-
based difference was linked to: (1)  increased muscle deoxygenation to VO2 ratio as a 
consequence of  a dispersal of microvascular blood flow distribution at the working 
muscle (Murias et al., 2013), and/or (2) a blunted vasodilatory response in females 
associated with limited baroreflex sensitivity to decreases in blood pressure that resulted 
in reduced muscle microvascular blood flow (Christou et al., 2005). Importantly, the 
aforementioned work did not control for menstrual phase making it uncertain whether 
results were menstrual phase dependent. FOL to LUT phase increases in blood flow and 
oxygen delivery, however, have been linked to enhanced pulmonary diffusion capacity 
(Smith, Brown, Murphy, & Harms, 2015) and arterial vasodilation (Gerhard et al., 1998) 
that may result in a LUT phase specific reduction in muscle deoxygenation.   
The main purpose of this study was to compare VO2, [La-], VE, vastus lateralis 
DHHb, and performance (time-to-fatigue) in both the early-follicular (FOL) and mid-
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luteal (LUT) phases of the menstrual cycle during ramp incremental and subsequent 
severe-intensity constant load exercise to limit of tolerance. In terms of a research 
hypothesis, if the LUT, compared to the FOL phase is associated with lower arterialized 
blood lactate concentrations concomitant with increased VE, VO2 and enhanced local 
muscle blood flow distribution (shown as lower DHHb/VO2) then improved performance 
on incremental and severe-intensity constant load exercise should be observed.  
2.1 « Methods » 
Participants performed a ramp incremental exercise test (via cycle ergometer) followed 
by a constant load, severe intensity step-exercise to fatigue at 101% of their peak power 
attained during the ramp test. This protocol was performed during LUT and FOL phases 
of the menstrual cycle to assess their effects on gas exchange, vastus lateralis 
deoxygenation, and time to fatigue at a work rate in the proximity of peak aerobic power.  
2.1.1 « Participants » 
An advertisement poster on Western University campus was used to assist with volunteer 
participant recruitment (see Appendix E). Inclusion criteria included females who 
reported to be healthy and active (moderate-intensity exercise 1-3 times per week). 
Exclusion criteria included those who reported irregular menstrual cycles (< 21 or > 45 
days), demonstrated a LUT phase deficiency, appeared to be anovulatory or ovulation 
could not be verified by urinary hormone testing, reported the use of hormonal 
contraceptives within six months of participation, taking medication that may have 
affected their metabolic, cardiorespiratory or hemodynamic responses to exercise, and 
reported a history of smoking.  
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2.1.2 « Ethical Approval » 
Participants provided informed written consent via an approved Letter of Information 
form (see Appendix B) by the Health Sciences Research Ethics Board, Western 
University, and this work was conducted according to the ethical standards of the 
Declaration of Helsinki (Appendix A). 
2.1.3 « Menstrual Cycle Phase Determination » 
The follicular (FOL; Day 1 to ~ Day 14) and luteal (LUT; ~ Day 14 to Day 28) phases of 
the ~28-day menstrual cycle are separated by ovulation (~ Day 14). The onset of the FOL 
phase in the present study was verified by the onset of menstrual flow (Day 1) and 
exercise testing took place on Day 2 of this phase. The progressive rise in estrogen in the 
late FOL phase (~ Day 12), elicits a surge in luteinizing hormone (LH). The resulting 
ovulation and concomitant increase in progesterone 24-36 hours later (Schaumberg, 
Jenkins, Janse de Jonge, Emmerton, & Skinner, 2017) indicates the beginning of the LUT 
phase and was verified via urinary hormone testing (AccuMed 100-Count Ovulation 
(LH) Test Strips, AccuMed BioTech LLC, Houston, Texas). Progesterone reaches peak 
concentrations approximately six days after a positive test is detected (Reilly, 2010; 
Schaumberg et al., 2017) and the LUT phase exercise testing was performed six days 
after the verified LH surge. All participants performed the exercise testing protocol 
detailed below in each of the FOL and LUT phases. The order of the menstrual phase 
testing was counterbalanced so that 5 females began testing in the FOL phase and 5 in the 
LUT.  
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2.1.4 « Exercise Testing Protocol » 
All tests were performed on an electromagnetically braked cycle ergometer (Velotron, 
RacerMate Inc. Seattle, WA). A ramp incremental test (RAMP), including a 4-min 
baseline at 20 W followed by a linear increase in power output equivalent to 20 W min-1 
to exhaustion was performed. After a five-minute recovery period at 20 W, a constant 
load, severe intensity (SI) step exercise was performed to exhaustion at 101% of peak 
aerobic power (PAP). Exhaustion was determined when a cadence of 70 revolutions per 
minute (rpm) could not be maintained. Verbal encouragement was provided by the 
research team to facilitate maximal effort by participants.  
One month prior to study onset, participants provided written consent and were 
informed of the exercise protocol. On the same day, participants completed a 
familiarization ride including both RAMP and SI protocols to acclimatize themselves 
with the testing procedures. All tests were performed in an overnight fasted, and hydrated 
state between 6:30am and 10am. Upon arrival to the lab, weight and height 
measurements were recorded. Participants were instructed to maintain their usual 
exercise and sleep regimens throughout the testing period. Nutritional food intake was 
also recorded 72 hours prior to their first ramp cycle ergometer test using a written food 
journal (Appendix C). An identical diet regimen was followed preceding the second day 
of testing to control for carbohydrate and protein oxidation rates that can be affected by 
dietary food intake during the subsequent phase tests (Bonen et al., 1983). 
2.1.5 « Measurements » 
During both RAMP and SI rides, local muscle deoxygenation ([HHb]) profiles from the 
quadriceps vastus lateralis were continuously monitored second by second via near-
27 
 
infrared spectroscopy (NIRS; Oxiplex TA, model 95205, ISS, Champaign, IL). NIRS 
measurements were collected and recorded via well-established methods (Murias et al., 
2013). In particular, an emission probe carrying near infrared (NIR) light was arranged as 
a single channel consisting of eight laser diodes operating at two wavelengths (690 and 
828 nm, 4 at each wavelength) that were pulsed in a rapid succession (frequency 
modulation of laser intensity was 110 MHz). The light returning from the tissue was 
detected by a photodiode for eventual display of the change (D) in [HHb], total 
hemoglobin concentration ([THb]), and oxygen saturation (O2Sat) from an exercising 
baseline of load less cycling (20 W) in the 30 s prior to the onset of the work rate. The 
optodes were contained in an optically dense plastic holder, which was placed on the 
muscle belly midway between the lateral epicondyle and greater trochanter of the femur. 
The probe was secured by a tightened elastic strap, an optically dense black vinyl sheet, 
and a tensor bandage to prevent movement and the intrusion of extraneous light. The 
NIRS probe was placed in the identical position, as demarcated by permanent marker, for 
each testing session. 
Inspired and expired gas volumes and concentrations were sampled continuously 
at the mouth and analyzed every 20 ms for oxygen (O2), carbon dioxide (CO2), and 
nitrogen (N2) by mass spectrometry (AMIS 2000; Innovision, Lindvedvej, Denmark) 
after calibration with precision-analyzed gas mixtures. These data were transferred to a 
computer, which aligned gas concentrations with volumes to build a profile of each 
breath to provide measures of oxygen uptake (VO2), carbon dioxide output (VCO2p), 
ventilation (VE), end-tidal oxygen pressure (PETO2), end-tidal carbon dioxide pressure 
(PETCO2), and breathing frequency (BF). Peak oxygen uptake (VO2peak) was determined 
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from the highest 20-breath average value. If there were no differences in VO2peak between 
the RAMP and SI rides, this was determined to verify the participant’s VO2max (Rossiter, 
Kowalchuk, & Whipp, 2006).  Oxygen uptake at estimated gas exchange threshold 
(VO2GET), synonymous with lactate threshold, was defined as the point in which VCO2 at 
which began to increase out of proportion to VO2, coinciding with a systematic rise in VE 
and PETO2 (Neder & Stein, 2006).  
Five arterialized-capillary blood samples were obtained and analyzed for lactate 
concentrations ([La-]): three min pre- RAMP, at 150 watts (W) during RAMP, post- 
RAMP, and both immediately post- and three minutes post- SI, as outlined in Figure 4. 
Samples taken immediately post-RAMP and post-SI were taken within 5 seconds of 
exercise cessation to ensure consistency among all participants. [La-] were measured 
using a Lactate Scout analyzer (Sports Resource Group, Hawthorne, NY). A 0.2 µl blood 
sample was taken with AccuChek Safe-T-Pro Plus Lancets. The participant’s index finger 
was sterilized with a rubbing alcohol swab prior to each blood draw. Latex gloves were 
worn by the researcher. All testing took place in the Canadian Center for Activity and 
Aging Cardiorespiratory Research Lab at Western University. 
2.1.6 « Data Analyses » 
VO2 data were filtered by removing aberrant data points lying outside four standard 
deviations of the local mean and linearly interpolated to 1 s intervals which were then 
binned into 5 s averaged response for each participant. The second-by-second D[HHb] 
data were averaged in a similar fashion. VO2p data were left-shifted by 20 s to account for 
the transit time lag in blood flow between the muscle and the lung to ensure that changes 
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in muscle VO2 (as represented by VO2p), were aligned with changes in the D[HHb] signal 
(Murias, Spencer, Kowalchuk, & Paterson, 2011).  Baseline values for VO2 and D[HHb] 
were determined as an average of the last 120 s of the four minute 20 W baseline prior to 
the onset of the RAMP. Since RAMP and SI bouts varied in duration for each participant, 
the VO2 and D[HHb] responses were normalized from 0%-100% as previously described 
by (Murias et al., 2013). The on-transient response for VO2 was modeled using the mono-
exponential function:   
𝑌" = 𝑌$%&' + 𝑎𝑚𝑝	 1 −	𝑒0(20"3)/6  
In the above equation, Y(T) represents VO2p at any time (t), YBsln is the baseline VO2 
during the last 120 s of baseline 20 W cycling, 𝜏 is time-constant defined as the time for 
VO2 to increase to 63% of the steady-state increase, and TD is the time delay, which was 
allowed to vary freely to optimize accuracy of parameter estimates (Murias et al., 2011). 
Data were modeled from the end of the cardio respiratory phase I to the end of the SI 
exercise duration. End of phase I was determined by visual inspection of the second by 
second data as the point in which there was a sharp decrease from baseline values in end-
tidal O2 pressure and a sharp increase in VO2 (Whipp, Ward, Lamarra, Davis, & 
Wasserman, 1982).  MRT in the present study is represented by the 𝜏 in the above 
equation.  
2.1.7 « Statistical Analyses » 
In most cases, data were analyzed via 2 (menstrual phase: LUT, FOL) by 20 (time: five 
percent increments from the onset of the RAMP and constant load exercise to volitional 
fatigue) fully repeated measures ANOVA. An alpha level of 0.05 was adopted and 
30 
 
significant main effects/interactions were decomposed via simple-effects (i.e., paired-
sample t-tests). Data is presented as mean ± standard deviation. 
2.2 « Results » 
2.2.1 « Participants » 
Participant means included age (22 years ± 1), weight (64 ± 8 kg) and height (167 ± 7 
cm). 
2.2.2 « Ramp Incremental Exercise » 
D[HHb]/DVO2p produced a menstrual phase by time interaction, F(20,180)=1.83 
(p=0.020), indicating that values for the LUT phase were lower than the FOL phase at 
15% (p=0.027), 20% (p=0.008), and 25% (p=0.022) of the RAMP protocol, whereas at 0 
to 10% and 30 to 100% values did not reliably differ between phases (all p>0.05) (Fig. 
5C). In terms of VCO2 (Table 3), VO2 (Figure 5A), D[HHb] (Figure 5B), VE (Table 3), 
VO2GET (Table 1), VO2D50 (Table 1), VO2max (Table 1), oxygen saturation (O2Sat) (Table 
4), total hemoglobin concentration ([THb]) (Table 4), PAP and TTF (Table 1), no reliable 
main effects or interactions were observed (all p>0.05).  In contrast, PETCO2 produced a 
main effect, F(1,9)=19.10, p=0.002), such that PETCO2 values were lower in the LUT 
compared to the FOL phase (Cohens d = 0.4)  (Table 3). 
We examined arterialized-capillary [La-] values at 3-minutes pre-RAMP, at 150 
W during RAMP, and immediately post-RAMP (Table 2) via a 2 (menstrual phase: LUT, 
FOL) by 3 (time: pre-RAMP, 150 during RAMP, post-RAMP).  Results did not elicit any 
reliable main effects or an interaction (p>0.05).   
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2.2.3 « Severe-Intensity Step Exercise » 
D[HHb]/DVO2p produced a menstrual phase by time interaction, F(20,180)=1.44, 
p=0.020) indicating that values for the LUT phase were lower than the FOL phase at 15% 
(p=0.002) and 20% (p=0.005) (Fig. 5F) of the SI protocol. For the other time points we 
did not observed any reliable differences (p>0.05). In terms of VCO2 (Table 3), VO2 
(Figure 5D), D[HHb] (Figure 5E), BF (Table 3), time-to-fatigue (TTF) (Table 1), O2Sat 
(Table 4), [THb] (Table 4), and mean response time (MRT) (Table 3), we did not observe 
any reliable main effects or interactions (all p>0.05).  In contrast, mean VE and PETCO2 
produced main effects, all F(1,9)=6.09 and 3.84, respectively, ps=0.036, and 0.082. VE 
was higher in the LUT phase compared to the FOL phase (Cohens d = 0.3) (Table 3) and 
PETCO2 was lower in the LUT compared to the FOL phase (Cohens d = 0.4) (Table 3). 
Arterialized-capillary [La-] values were examined immediately post-SI (within 5 seconds) 
and 3-minutes post-SI, via a 2 (menstrual phase: LUT, FOL) by 2 (time: post-SI, 3 min 
post-SI) ANOVA. Results elicited an interaction, F(1,9)=2.38, p=0.070), indicating that 
post-SI [La-] values were lower in LUT phase compared to FOL (p=0.037, Cohen’s d = 
0.6) , whereas 3-min post-SI LUT and FOL phase values did not differ (p>0.05). 
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Table 1. Group mean data ± SD for VO2GET, VO2D50, VO2max, 
VCO2peak, PAPRAMP, POSI, TTFRAMP, and TTFSI in both FOL and LUT 
phases. 
Variable  Unit FOLLICULAR LUTEAL 
VO2max L×min-1 2.36 ± 0.4 2.36 ± 0.4 
VCO2peak L×min-1         2.51 ± 0.5    2.48 ± 0.4 
VO2D50 L×min-1 1.77 ± 0.3 1.80 ± 0.3 
VO2GET L×min-1 1.17 ± 0.2 1.23 ± 0.2 
PAPRAMP  W 218 ± 35 221 ± 29 
POSI W 220 ± 35 223 ± 29 
TTFRAMP s 654±112 661 ± 93 
TTFSI  s 99.2 ± 20 95.8 ± 15 
Data analyzed by paired t-tests. RAMP (ramp incremental exercise 
test) SI (severe-intensity step-exercise test) FOL (early-follicular 
phase) LUT (mid-luteal phase) VO2GET (oxygen uptake at estimated 
gas exchange threshold during RAMP exercise) VO2D50 (oxygen 
uptake at 50% of the difference between VO2GET and VO2peak from 
RAMP exercise) VO2max (maximal pulmonary oxygen uptake as 
determined by the mean peak values from RAMP and SI. No 
differences between VO2peak in RAMP and SI were found, p>0.05)  
VCO2peak (peak carbon dioxide production) PAP (peak aerobic power 
output from RAMP exercise) POSI (power output during SI exercise) 
TTF (time-to-fatigue from SI exercise) L×min-1 (litres per minute) W 
(watts) s (seconds).  
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Table 2. Group mean data ± SD for arterialized-capillary [La-] during 
RAMP and SI tests in both FOL and LUT phases. 
Variable  Unit FOLLICULAR LUTEAL 
3-min Pre-RAMP mmol×L-1 1.5 ± 0.3      1.4 ± 0.3 
150 W mmol×L-1 4.2 ± 1.5     4.7 ± 2.0 
Post-RAMP mmol×L-1 10.2 ± 2.2     10.8 ± 2.2 
Post-SI mmol×L-1 12.9 ± 2.5 11.7 ± 1.7 * 
3-min Post-SI mmol×L-1 12.8 ± 2.5     12.1 ± 2.3 
Data analyzed by paired t-tests. RAMP (ramp incremental exercise test) 
SI (severe-intensity step-exercise test) FOL (early-follicular phase) LUT 
(mid-luteal phase) [La-] (arterialized-capillary blood lactate 
concentration) 3-min Pre-RAMP ([La-] 3 minutes prior to start of RAMP) 
150 W ([La-] during RAMP when participants reach a work rate of 150 
watts) Post-RAMP ([La-] at end of RAMP test) Post-SI ([La-] at end of SI) 
3-minutes Post-SI ([La-] 3 minutes after the end of the SI) mmol×L-1 
(millimole per litre). * LUT phase is significantly different from FOL 
(p<0.05). 
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Table 3. Group mean data ± SD for VE, BF, PETCO2, VCO2, RER and MRT 
during RAMP and SI tests in both FOL and LUT phases. 
  RAMP SI 
Variable Unit FOL LUTEAL FOL LUTEAL 
VE L×min-1 53 ± 25 55 ± 25 83 ± 20 89 ± 17 * 
BF Brth/min 32 ± 4 35 ± 5 45 ± 5 48 ± 8 
PETCO2 mmHg 37 ± 2 36 ± 3 * 27 ± 2 26 ± 3 § 
VCO2 L×min-1 1.52 ± 0.7 1.56 ± 0.7 1.90 ± 0.5 1.92 ± 0.4 
RER  0.97 ± 0.14 0.97 ± 0.12 0.96 ± 0.09 0.96 ± 0.07 
MRT s -- -- 29.3 ± 6 28.6 ± 8 
Data analyzed by 2 Way RM ANOVA. RAMP (ramp incremental exercise test), 
SI (severe-intensity step-exercise test) FOL (early-follicular phase), LUT (mid-
luteal phase), VE (ventilation), BF (breathing frequency), PETCO2 (end-tidal carbon 
dioxide pressure), VCO2 (carbon dioxide production), RER (respiratory exchange 
ratio), MRT (mean response time), L×min-1 (litres per minute), Brth/min (breaths 
per minute), mmHg (millimeters of mercury) and s (seconds). LUT phase is 
significantly different from FOL * (p<0.05); § (p=0.08).  
 
 
35 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Group mean data ± SD for NIRS measurements including ∆HHb, [THb] 
and O2Sat during RAMP and SI in both FOL and LUT phases. 
  RAMP SI 
Variable Unit FOL LUTEAL FOL LUTEAL 
∆HHb % 55.9 ± 30 50.5 ± 33 84.8 ± 21 83.0 ± 21 
[THb] a.u. 1.87 ± 1.0 2.16 ± 1.3 2.75 ± 0.3 3.27 ± 0.2 
O2Sat % 67.72 ± 2.3 68.45 ± 2.2 64.27 ± 1.9 64.46 ± 2.3 
Data analyzed by 2 Way RM ANOVA. RAMP (ramp incremental exercise test). SI 
(severe-intensity step-exercise test), FOL (early-follicular phase), LUT (mid-luteal 
phase), ∆HHb (change in muscle deoxygenation of the vastus lateralis), [THb] (total 
hemoglobin concentration at the vastus lateralis), O2Sat (oxygen saturation at the 
vastus lateralis), % (percent of maximum response) and a.u. (arbitrary units).  
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Figure 4. Schematic diagram of the RAMP and SI exercise protocols, including timing of 
arterialized capillary blood lactate samples (L); L1 (taken 3-minutes prior to onset of 
exercise), L2 (taken at 150W during ramp incremental exercise), L3 (taken immediately 
at ramp test cessation), L4 (taken immediately at cessation of severe-intensity step 
exercise at 101% of peak aerobic power), L5 (taken 3-minutes post exercise cessation)  
RAMP (ramp incremental exercise test), SI (severe-intensity step-exercise test), PAP 
(peak aerobic power).  
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Figure 5. (A-F). Group means for A) VO2p during RAMP, B) ∆HHb during 
RAMP, C) ∆HHb/VO2p during RAMP, D) VO2p during SI, E) ∆HHb during 
SI, F) ∆HHb/VO2p during SI. Open circles ( ○ ) represent the early-follicular 
(FOL) phase and closed circles ( • ) represent the mid-luteal (LUT) phase. VO2 
(pulmonary oxygen uptake) L×min-1 (litres per minute) DHHb (change in vastus 
lateralis muscle deoxygenation) A.u. (arbitrary units) DHHb/VO2 (change in vastus 
lateralis muscle deoxygenation DHHb (a.u.) over oxygen uptake (L×min-1)). RAMP 
(ramp incremental test) and SI (severe-intensity step-exercise) varied in duration for 
each participant, therefore the average and time-aligned VO2 and D[HHb] responses 
were then normalized from 0% to 100%, such that 0% represented the start of the 
tests and 100% represented test cessation. * LUT phase is significantly different from 
FOL (p<0.05). 
38 
 
2.3 « Discussion » 
The purpose of this study was to compare VO2, [La-], VE, vastus lateralis DHHb, and 
performance (time-to-fatigue) in both the early-follicular and mid-luteal phases of the 
menstrual cycle during ramp incremental and subsequent severe-intensity constant load 
exercise to limit of tolerance. The main findings demonstrated that: (1) the RAMP 
protocol elicited lower muscle deoxygenation  at O2  uptakes below gas exchange 
threshold during RAMP exercise in the LUT compared to the FOL phase – a result that 
was independent of menstrual phase differences in gas exchange variables or blood 
lactate, and (2) the severe-intensity exercise stimulus elicited higher mean ventilation and 
lower post-SI lactates in LUT compared to FOL, whereas the change in muscle 
deoxygenation to oxygen uptake ratio was lower during the kinetic phase in the LUT 
compared to the FOL; and (3) LUT and FOL phase performance during RAMP and 
severe intensity exercise were not associated with observable performance differences. 
The discussion first outlines results for the RAMP incremental test and then for the 
severe intensity test.  In outlining these results, we note the importance of delineating 
both the identified similarities and differences in LUT and FOL phase performance and 
physiological measures within the context of the previous literature.   
2.3.1 « Ramp Incremental Exercise » 
The null difference FOL and LUT phase VO2max values in RAMP and SI bouts adds to a 
growing body of evidence showing that cardiorespiratory performance does not vary with 
menstrual phase (Jurkowski et al., 1978; Redman et al., 2003; Schoene et al., 1981). The 
VO2 response at moderate power outputs, however, remains equivocal as the more recent 
paper of Redman at al. (2003) observing modest increases in VO2 from sub-lactate to 
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supra-lactate threshold power outputs in LUT compared to FOL are in juxtaposition to 
Gurd et al. (2007) and the current study in which menstrual phase VO2 differences at sub-
lactate threshold work rates were not observed. That in mind, Redman et. al (2003) tested 
participants in the mid-follicular phase (Days 5-7), when estrogen is in higher 
concentration compared to early-FOL, and might have effected oxygen uptake and gas 
exchange variables.   
The hypothesized FOL to LUT phase increased VE and decreased [La-] at 
VO2max during RAMP was not observed. This is similar to the unchanged peak VE 
observed by Redman et al. (2003).  In contrast, PETCO2  showed a >1 mmHg reduction in 
the LUT compared to the FOL phase – a salient finding given that this measure provides 
a non-invasive reflection of pulmonary capillary carbon dioxide pressure and a key 
stimulus on VE (Benallal & Busso, 2000). It has been suggested that a 1 mmHg decrease 
in PETCO2, elicits a 2.6 L×min-1 decrease in VE during exercise (Clark & Godfrey, 1969). 
The unchanged VE during RAMP, concomitant with the reduction in LUT phase PETCO2 
indicates that this change in gas pressure did not elicit a physiologically meaningful 
stimulus on VE under RAMP conditions between menstrual phases. PETCO2 data results 
were not presented by Redman et al. (2003) so no comparisons can be made. 
It is suggested that the unchanged mean VCO2 , VE and [La-] between menstrual 
phases in the present study, coupled with the reduced pulmonary capillary PCO2 , as 
reflected by PETCO2 (Table 3), in the LUT phase was a function of the previously 
observed enhanced LUT phase pulmonary diffusion capacity (Farha et al., 2007) and 
pulmonary vasodilation (Gerhard et al., 1998). Both of these LUT specific responses 
would facilitate greater pulmonary capillary to alveolar CO2 transfer and underpin the 
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observed decrease in PETCO2 and unchanged [La-] (Table 2), commensurate with the 
unchanged ventilatory buffering, as reflected by the stable VCO2max between menstrual 
phases (Table 1). The previously observed reduction of VCO2 at maximal exercise with 
similar peak lactates during RAMP (Redman et al., 2003) also suggests that the increased 
LUT phase pulmonary diffusion capacity (Farha et al., 2007) and pulmonary vasodilation 
(Gerhard et al., 1998) has increased CO2 transfer across the pulmonary capillary/alveolar 
interface eliciting increased removal of CO2.  
 Previous research examining muscle deoxygenation during ramp exercise has 
suggested that women, compared to men, have decreased microvascular blood flow to 
oxygen uptake (higher D[HHb]/VO2) below the respiratory compensation threshold. This 
has been taken to evince that women have a greater reliance on muscle deoxygenation 
(Murias et al., 2013). The present study showed that women in the LUT phase, compared 
to FOL, exhibited reduced reliance on muscle deoxygenation as a function of improved 
microvascular blood flow (lower D[HHb]/VO2) below GET. This LUT response has also 
been observed in post-menopausal women undergoing estrogen therapy (inducing LUT 
phase conditions), and was shown to enhance endothelium-dependent vasodilation 
(Gerhard et al., 1998; Gilligan, Quyyumi, Cannon, Johnson, & Schenke, 1994). This 
explanation provides a parsimonious account for the decreased LUT muscle 
deoxygenation to O2 utilization observed in the present study. Moreover, Farha et al. 
(2007) found that ovariectomized mice, undergoing estrogen supplementation to mimic 
the LUT phase, showed increased pulmonary capillary density. This resulted in an 
increased surface area for gas diffusion (Farha et al., 2007). This would, in combination 
with the aforementioned LUT phase vasodilation (Gerhard et al., 1998; Gilligan et al., 
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1994), enhance blood flow and also be reflected in the observed decrease of 
D[HHb]/DVO2p in the LUT phase of the present study.  
These aforementioned LUT phase improvements of microvascular blood flow to 
oxygen uptake (Figure 2C) in the present study were unaffected at exercise intensities 
above GET. Above GET, the menstrual phase differences were not significant and 
become increasingly smaller as exercise intensity increases. This may be due to improved 
microvascular perfusion by enhanced vasodilation, which would be mediated by higher 
lactate production and the accompanying acidosis that occurs during heavy intensity 
exercise (Stocker, Von Oldershausen, Paternoster, Schulz, & Oberhoffer, 2017). 
This demonstrates that under these higher intensity-conditions, the observed 
limitation in microvascular blood flow has been resolved and no change in RAMP 
performance (i.e. VO2max, PAP, TTF) would be expected and none were observed (Table 
1).  
2.3.2 « Severe-Intensity Step Exercise » 
Similar to RAMP, VO2 was unchanged between FOL and LUT phases and is in accord 
with previous work (Jurkowski et al., 1978; Redman et al., 2003; Schoene et al., 1981).  
In contrast to the RAMP response, however, the LUT phase produced a larger VE and 
lower PETCO2 compared to the FOL phase (Table 3). It is suggested that this increased VE 
has elicited the observed reduction of PETCO2, as well as buffered, in part, the anaerobic 
glycolytically produced [H+]. This would be reflected in the observed increase in VE and 
the contemporaneous observed reduction in [La-] immediately post-SI (Table 2).  [La-] 3-
minutes post-SI was not different in FOL and LUT phases, and as there is no ventilation 
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data for the 3-minute recovery period, we cannot comment on the underlying 
mechanisms explaining the null changes in [La-] 3-minutes post-SI. 
Others have attributed reduced [La-] in the LUT phase to increased fat oxidation 
resulting in glycogen sparing (Bunt, 1990; Hackney, McCracken, & Ainsworth, 1994; 
Jurkowski, Jones, Toews, & Sutton, 1981; McCracken et al., 1994). Furthermore, animal 
research has shown that progesterone treatment decreases Glut-4 protein content in 
insulin-responsive tissue, thereby reducing glucose transport into the cell during exercise 
and resulting in a greater reliance on fats as a fuel source (Campbell & Febbraio, 2001). 
Further, increased fat oxidation and lower glucose uptake in the LUT phase during a 
maximal effort time-trial performance in a fasted state has been observed (Campbell, 
Angus, & Febbraio, 2001). Females in the present study consumed identical diets in each 
menstrual phase for the 72 hours preceding testing, and all tests were performed in a 
similar fasted state to ensure that if substrate oxidation was to be menstrual phase 
dependent, changes in RER, a proxy for fat and carbohydrate oxidation rates, that this 
difference would not be precipitated by diet related changes in substrate oxidation. No 
differences in substrate oxidation, as reflected by RER (Péronnet & Massicotte, 1991) 
between FOL and LUT, during the pre- RAMP or pre-SI steady state light-intensity 
periods,  or throughout either the RAMP or SI bouts (p>0.05; Table 3) were observed. 
Our data purport that menstrual phase is independent of substrate oxidation. 
These aforementioned RAMP and SI differences between LUT and FOL phases 
observed in the present study indicate that the divergent contributions from the oxidative 
and non-oxidative phosphorylation energy systems coupled with different VO2 kinetic 
activation demands of these exercise bouts resulted in a differential physiological 
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cardiorespiratory and metabolic responses. Notably, the non-oxidative phosphorylation 
contributions for RAMP, and the 90 s SI bout, have been estimated to be < 10% (Bertuzzi 
et al. 2013) and ~ 45% respectively (Gastin, 2001). Moreover, the mean response time of 
VO2 of ~29 s during SI of the present study demonstrates a distinctly speeded activation 
of the phosphorylation systems to reach peak aerobic power (via the square application of 
the work rate) compared to the 14-min linear increase in power output during RAMP to 
attain the same work rate (Table 1).   
The similar SI VO2 kinetics for LUT and FOL phases reported here, and the 
observed LUT reduction of the D[HHb]/DVO2p during the kinetic phase of SI, 
demonstrated the FOL to LUT transition to enhanced microvascular blood flow. It is 
suggested that the unchanged VO2 kinetics during the FOL compared to the LUT phase 
represents an increased reliance on muscle deoxygenation that is supported by LUT 
enhanced vasodilation and diffusion capacity that has been observed elsewhere (Christou 
et al., 2005; Gerhard et al., 1998; Gilligan et al., 1994). Others have associated the LUT 
increase in microvascular blood flow to enhanced blood volume and total hemoglobin 
concentration compared to the FOL-related reduction in blood volume and hemoglobin 
loss (Reilly, 2010),  However, [THb] and O2Sat in the present study were unchanged 
(p>0.05, Table 4) and as such, our data suggest that the changes in deoxygenation are the 
result of improved microvascular blood flow distribution via the aforementioned 
improved diffusion capacity and vasodilation. Accordingly, the SI and RAMP results 
reported here indicate that O2 delivery is sustained by increased blood flow during LUT 
and increased deoxygenation during FOL. 
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2.4  « Conclusion » 
To our knowledge, this is the first study to examine menstrual phase differences in gas 
exchange, muscle deoxygenation and performance during RAMP and SI exercise. RAMP 
results indicate that LUT phase O2 delivery is sustained by enhanced muscle blood flow 
distribution below gas exchange threshold, where FOL phase O2 extraction and delivery 
is sustained via increased muscle deoxygenation below gas exchange threshold. LUT 
phase SI results indicated lower post exercise [La-] and PETCO2 as a function of increased 
VE associated with ventilatory buffering. Further, the LUT phase kinetic portion of SI 
shows enhanced microvascular blood flow, whereas FOL phase VO2 is sustained via 
increased muscle deoxygenation during the kinetic phase. In contrast to our hypothesis, 
although we have found changes in muscle deoxygenation, ventilation, and blood lactate 
concentrations between menstrual phases, there are no consequential deleterious effects 
during moderate to exhaustive exercise in recreationally active females. The social 
impact of this study includes the determination that recreationally active females do not 
have to be concerned that menstrual phase will impact exercise and/or performance. 
2.5 Future Direction and Limitations 
To our knowledge, the only limitation of the present study is the small sample size 
(n=10). Future research could investigate different subject populations including female 
athletes, sedentary females, and females who use oral contraceptives to determine the 
effects of exogenous ovarian hormones.   
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Appendix C: Three Day Food Tracker 
 
 
3 Day Food Tracker: Ramp Incremental Exercise Study  
 
Instructions for Use:  
This food tracker is to be used for the 3 days prior to the first wave of testing. Jordyn will tell you when you are 
to start using it. You are to write what your meals and snacks are for each day and count how many glasses of 
water (or herbal tea) you have throughout the day. Some people find it helpful to take pictures of their meals 
while keeping a diary to help with portion sizes. An example ‘day’ is outlined for you below: 
 
Example: 
Date Breakfast  Lunch  Dinner Snacks Water/ 
Herbal 
Tea 
Ex1 Coffee  
Granola – 1 cup  
Low fat vanilla 
yogurt cup  
Banana 
Spinach salad with 
chicken  
Balsamic dressing  
Chocolate milk  
Salmon 
Brown rice (~3/4 
cup) 
Steamed broccoli and 
carrots. 
Dark chocolate 
& almond 
granola bar  
 
Popcorn 
(dessert) 
 
8  
 
Your Meal Tracker: 
Date   Breakfast  Lunch  Dinner Snacks Water/ 
Herbal 
Tea 
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Appendix D: Ovulation Testing Stick Instructions 
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Appendix E: Advertisement Poster 
 
 
 
Advertisement 
 
 
 
 
 
The Effects of Periodic Breath Holding During Intermittent Exercise on Energy 
System Contribution, Lactate Threshold, and Regional Blood Flow Distribution 
will be studied  
 Principle Investigator- Glen Belfry 
 Co-investigator- Jordyn Smith 
 
 We are seeking volunteers for a study that examines the energy system 
contribution, lactate threshold, and regional blood flow distribution to periodic breath 
holding during intermittent exercise. 
 
The experiment will be conducted at the Centre for Activity and Aging using 
breath-by-breath oxygen uptake and near infrared spectroscopy. Participants will be 
required to come into the laboratory eight times a total of eight tests.    
 
The study involves a total of 9 visits, with 1 test per visit. The first visit will be 
approximately 45 min long and will involve reading and signing a letter of information 
and an exercise test for determination of your maximal oxygen uptake test. On the 
second visit, another maximal oxygen uptake test will be completed with an intermittent 
breath holding (5 sec) and 25 sec normal breathing. Test 3 is a 6 min continuous trial at  
a moderately hard intensity. Test 4 is a 6 min continuous trial at moderately hard 
intensity with the intermittent breath holding protocol. Test 5 is a 6 min moderately hard 
intensity intermittent exercise with the intermittent hypoxia protocol (5 sec high power 
output with breath holding and 25 sec at moderately hard intensity with normal 
breathing). Test 6, 7, 8 will be a repeat of test 3, 4, 5, respectively. 
 
 
Volunteers must be healthy, non-smoking, females 
between the ages of 18 and 35. 
  
 
Interested individuals are asked to contact: 
   Jordyn  (519) 270-8693     (jsmit577@uwo.ca)      
WANTED: 
PARTICIPANTS FOR AN EXERCISE PHYSIOLOGY    
EXPERIMENT 
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